APA Zitierstil

Lynce, F., Wang, H., Petricoin, E. F., Pohlmann, P. R., Smaglo, B., Hwang, J., . . . Pishvaian, M. J. (2019). A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies. Cancer Chemother Pharmacol.

Chicago Zitierstil

Lynce, Filipa, et al. "A Phase I Study of HER1, HER2 Dual Kinase Inhibitor Lapatinib Plus the Proteasome Inhibitor Bortezomib in Patients With Advanced Malignancies." Cancer Chemother Pharmacol 2019.

MLA Zitierstil

Lynce, Filipa, et al. "A Phase I Study of HER1, HER2 Dual Kinase Inhibitor Lapatinib Plus the Proteasome Inhibitor Bortezomib in Patients With Advanced Malignancies." Cancer Chemother Pharmacol 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.